Article Details

AstraZeneca says Alexion receives recommendation to use rare blood disorder drug in kids

Retrieved on: 2021-07-26 07:07:30

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca says Alexion receives recommendation to use rare blood disorder drug in kids. View article details on HISWAI: http://www.proactiveinvestors.co.uk/companies/news/955923/astrazeneca-says-alexion-receives-recommendation-to-use-rare-blood-disorder-drug-in-kids-955923.html

Excerpt

AstraZeneca PLC (LON:AZN) announced that Alexion's Ultomiris has been recommended for marketing authorisation in the EU for expanded use to ...

Article found on: www.proactiveinvestors.co.uk

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up